TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYOPINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

MYOPINE

ST13

US500000079227136

Class

5

Filing

79227136

Registration

5592609

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

01/23/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

01/04/2018

Registration date

10/30/2018

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/16/2025

Last transaction

01/23/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

SG

Examiner

SETTLES LEWIS, SHAILA E

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "Myopine" with the letter "o" appearing as a human eye.

Holders and representatives

Holders

SINGAPORE NATIONAL EYE CENTRE PTE LTD

Representatives

RODYK IP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Eye drops; pharmaceutical preparations for the treatment of the eyes; pharmaceutical and medicinal preparations and substances for the treatment of ophthalmic related diseases and disorders

Publications

History of USPTO decisions and trademark events.

28 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/22/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/16/2026

C71T

CANCELLED SECTION 71

05/16/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/11/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/27/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/26/2019

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

02/10/2019

XXCR

GENERIC MADRID TRANSACTION CREATED

02/09/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/30/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

10/30/2018

PUBO

PUBLISHED FOR OPPOSITION

08/14/2018

GPNX

NOTIFICATION PROCESSED BY IB

08/10/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/25/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/25/2018

NPUB

NOTICE OF PUBLICATION

07/25/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/02/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/10/2018

RFNT

REFUSAL PROCESSED BY IB

05/11/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/24/2018

RFRR

REFUSAL PROCESSED BY MPU

04/24/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/18/2018

CNRT

NON-FINAL ACTION WRITTEN

04/17/2018

DOCK

ASSIGNED TO EXAMINER

04/13/2018

MAFR

APPLICATION FILING RECEIPT MAILED

03/03/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/27/2018

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

02/15/2018

Continuous trademark protection

Get notified about every new filing that threatens MYOPINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.